Influence of Expected Blood Loss and Context on the Ratings for Erythropoietin Alone
| Indication | Context | ||
|---|---|---|---|
| Clinical | Cost constraint | Cost and blood supply constraint | |
| None, n = 64 | |||
| Mean score* | 2.4 | 1.7 | 2.2 |
| Variation from the clinical scenario† | NA | −0.7 (p = 0.0001) | −0.2 (p = 0.02) |
| 1–2 units of PRBCs, n = 64 | |||
| Mean score* | 6.3 | 4.3 | 5.9 |
| Variation from the clinical scenario† | NA | −2.0 (p < 0.0001) | −0.4 (p < 0.0001) |
| 3 or more units of PRBCs, n = 64 | |||
| Mean score* | 8.3 | 8.0 | 8.6 |
| Variation from the clinical scenario† | NA | −0.3 (p = 0.01) | 0.3 (p = 0.002) |